Allied Biotech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	821.81	806.92	720.43	716.75	676.76	618.07
Revenue Growth (YoY)	3.86%	12.01%	0.51%	5.91%	9.50%	-3.34%
Cost of Revenue	523.94	548.53	473.99	445.7	418.71	376.91
Gross Profit	297.87	258.38	246.44	271.05	258.05	241.15
Selling, General & Admin	145.63	144.15	131.64	144.71	120.64	112.85
Research & Development	27.35	26.12	26.09	24.56	25.74	24.57
Operating Expenses	173.78	170.27	157.73	171.27	146.38	138.59
Operating Income	124.09	88.12	88.71	99.78	111.67	102.57
Interest Expense	-17.39	-13.96	-12.96	-11.75	-11.25	-9
Interest & Investment Income	24.41	24.67	15.63	5.3	1.65	5.14
Currency Exchange Gain (Loss)	-15.59	30.92	29.88	88.11	-85.55	0.03
Other Non Operating Income (Expenses)	2.79	0.29	1.12	5.01	1.06	0.61
EBT Excluding Unusual Items	118.3	130.04	122.38	186.45	17.58	99.36
Gain (Loss) on Sale of Investments	-	-	-	-	-	2.33
Gain (Loss) on Sale of Assets	-0.86	-	-	-1.59	-	-0.23
Other Unusual Items	-	-	-	0.17	-	0.07
Pretax Income	117.45	130.04	122.38	185.04	17.58	101.53
Income Tax Expense	22.85	29.1	24.97	38.29	4.54	22.05
Net Income	94.59	100.94	97.41	146.74	13.04	79.47
Net Income to Common	94.59	100.94	97.41	146.74	13.04	79.47
Net Income Growth	-10.57%	3.62%	-33.62%	1025.14%	-83.59%	-25.66%
Shares Outstanding (Basic)	96	96	96	95	95	95
Shares Outstanding (Diluted)	96	96	96	96	95	95
Shares Change (YoY)	0.31%	0.37%	0.20%	0.43%	0.05%	0.22%
EPS (Basic)	0.98	1.05	1.02	1.54	0.14	0.84
EPS (Diluted)	0.98	1.05	1.01	1.53	0.14	0.83
EPS Growth	-10.90%	3.96%	-33.99%	1018.40%	-83.52%	-25.89%
Free Cash Flow	137.63	196.98	89.71	109.62	22.44	2.66
Free Cash Flow Per Share	1.43	2.04	0.94	1.14	0.23	0.03
Dividend Per Share	1.000	1.000	0.850	1.200	0.500	0.800
Dividend Growth	17.65%	17.65%	-29.17%	140.00%	-37.50%	-20.00%
Gross Margin	36.24%	32.02%	34.21%	37.82%	38.13%	39.02%
Operating Margin	15.10%	10.92%	12.31%	13.92%	16.50%	16.59%
Profit Margin	11.51%	12.51%	13.52%	20.47%	1.93%	12.86%
Free Cash Flow Margin	16.75%	24.41%	12.45%	15.29%	3.32%	0.43%
EBITDA	179.57	144.33	152.38	165.12	170.53	158.14
EBITDA Margin	21.85%	17.89%	21.15%	23.04%	25.20%	25.59%
D&A For EBITDA	55.48	56.21	63.67	65.34	58.86	55.57
EBIT	124.09	88.12	88.71	99.78	111.67	102.57
EBIT Margin	15.10%	10.92%	12.31%	13.92%	16.50%	16.59%
Effective Tax Rate	19.46%	22.38%	20.41%	20.70%	25.81%	21.72%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.